Zong-li Zhang

107 West Wenhua Road
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer.

ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer.

Journal: World journal of surgical oncology

Published: August 17, 2025

Correction: HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium.

Correction: HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium.

Journal: Oncogene

Published: July 29, 2025

PTPN9 dephosphorylates IGF1RY1165/1166 and alleviates IGF1R-mediated resistance to tyrosine kinase inhibitor in cholangiocarcinoma.

PTPN9 dephosphorylates IGF1RY1165/1166 and alleviates IGF1R-mediated resistance to tyrosine kinase inhibitor in cholangiocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 10, 2025

Prognostic analysis of lymph node resection and liver resection for T1b and T2 gallbladder cancer: a multi-center retrospective study.

Prognostic analysis of lymph node resection and liver resection for T1b and T2 gallbladder cancer: a multi-center retrospective study.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: December 29, 2024

EEF1AKMT4-eEF1A2 synergistically facilitates the progression of GBC by promoting ribosomal protein output.

EEF1AKMT4-eEF1A2 synergistically facilitates the progression of GBC by promoting ribosomal protein output.

Journal: Genes & diseases

Published: November 03, 2024

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma.

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma.

Journal: Frontiers in pharmacology

Published: May 23, 2024

Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC.

Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC.

Journal: Frontiers in pharmacology

Published: May 02, 2024

Establishment and validation of a nomogram containing cytokeratin fragment antigen 21-1 for the differential diagnosis of intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Establishment and validation of a nomogram containing cytokeratin fragment antigen 21-1 for the differential diagnosis of intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: March 21, 2024

SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1.

SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1.

Journal: Journal of cellular and molecular medicine

Published: June 01, 2023

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma.

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma.

Journal: Frontiers in oncology

Published: January 13, 2023

BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway.

BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway.

Journal: Cancer cell international

Published: November 14, 2022

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis.

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis.

Journal: Frontiers in oncology

Published: October 20, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026